Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Oncogene
|
February 26, 2022
Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction
Alexandra Landras, Coralie Reger de Moura, Bruno O Villoutreix, et al.
Oncogene
|
April 3, 2024
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1
Coralie Reger De Moura, Baptiste Louveau, Fanélie Jouenne, et al.
Experimental Dermatology
|
March 27, 2015
EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells
Julie Delyon, Farah Khayati, Ibtissem Djaafri, et al.
Blood
|
October 20, 2009
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
Faten Bougatef, Cathy Quemener, Sabrina Kellouche, et al.
The International Journal of Biological Markers
|
June 15, 2010
Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma
Bernard Paule, Emmanuelle Deslandes, St Phane E Le Mouel, et al.
Plos One
|
May 27, 2010
Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas
Bernard Paule, Laurence Bastien, Emmanuelle Deslandes, et al.
Oncotarget
|
April 1, 2015
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
Farah Khayati, Laura Pérez-Cano, Kamel Maouche, et al.
Experimental Dermatology
|
April 10, 2016
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma
Anne Caudron, Maxime Battistella, Jean-Paul Feugeas, et al.
Pigment Cell & Melanoma Research
|
July 5, 2019
Discoidin domain receptors: A promising target in melanoma
Coralie Reger de Moura, Maxime Battistella, Anjum Sohail, et al.
Oncotarget
|
October 27, 2014
A novel tumor suppressor function of Kindlin-3 in solid cancer
Ibtissem Djaafri, Farah Khayati, Suzanne Menashi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Oncogene
|
February 26, 2022
Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction
Alexandra Landras, Coralie Reger de Moura, Bruno O Villoutreix, et al.
Oncogene
|
April 3, 2024
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1
Coralie Reger De Moura, Baptiste Louveau, Fanélie Jouenne, et al.
Experimental Dermatology
|
March 27, 2015
EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells
Julie Delyon, Farah Khayati, Ibtissem Djaafri, et al.
Blood
|
October 20, 2009
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
Faten Bougatef, Cathy Quemener, Sabrina Kellouche, et al.
The International Journal of Biological Markers
|
June 15, 2010
Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma
Bernard Paule, Emmanuelle Deslandes, St Phane E Le Mouel, et al.
Plos One
|
May 27, 2010
Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas
Bernard Paule, Laurence Bastien, Emmanuelle Deslandes, et al.
Oncotarget
|
April 1, 2015
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
Farah Khayati, Laura Pérez-Cano, Kamel Maouche, et al.
Experimental Dermatology
|
April 10, 2016
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma
Anne Caudron, Maxime Battistella, Jean-Paul Feugeas, et al.
Pigment Cell & Melanoma Research
|
July 5, 2019
Discoidin domain receptors: A promising target in melanoma
Coralie Reger de Moura, Maxime Battistella, Anjum Sohail, et al.
Oncotarget
|
October 27, 2014
A novel tumor suppressor function of Kindlin-3 in solid cancer
Ibtissem Djaafri, Farah Khayati, Suzanne Menashi, et al.
Page
of 5